Investing Ideas
/
Polish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Header cover image

Polish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

UPDATED May 17, 2024

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

17 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	GEN Genomed Spólka Akcyjna	zł28.00	-4.8%	-30.0%	zł37.0m	n/a	PE37.3x	n/a	0%
	MOC Molecure	zł14.64	-5.1%	-28.8%	zł246.5m	zł34.00	PS179.2x	E-6.3%	n/a
	CTX Captor Therapeutics Spolka Akcyjna	zł76.00	-0.5%	-52.5%	zł353.1m	zł115.00	PS28.2x	E109.8%	n/a
	PTG Poltreg	zł47.10	-2.3%	-13.4%	zł219.6m	zł68.20	PS157x	E8.2%	n/a
	GX1 genXone	zł6.10	-12.6%	-37.8%	zł20.1m	n/a	PS8.4x	n/a	0%
	BIO BIOTON	zł3.55	0%	-1.7%	zł304.8m	n/a	PE134x	n/a	n/a
	BGD Biogened	zł22.40	1.8%	60.0%	zł55.0m	n/a	PE13.1x	n/a	1.8%
	BER Bioerg Spólka Akcyjna	zł0.14	0%	-17.6%	zł13.8m	n/a	PS46.1x	n/a	n/a
	SCS Stem Cells Spin	zł0.50	-3.8%	34.4%	zł20.7m	n/a	PS49.3x	n/a	n/a
	IGN Inno-Gene	zł1.70	-4.5%	-70.2%	zł10.5m	n/a	PS9.3x	n/a	n/a
	GMT Genomtec	zł12.60	-2.3%	34.0%	zł154.4m	n/a	PS154449.4x	n/a	n/a
	BCX Bioceltix	zł68.40	4.4%	0.3%	zł282.5m	n/a	PB27x	n/a	n/a
	RDG Read-Gene	zł4.99	2.3%	50.3%	zł58.8m	n/a	PS5.9x	n/a	n/a
	LCN Labocanna	zł0.42	-1.2%	-9.7%	zł8.9m	n/a	PS101.7x	n/a	n/a
	MAB Mabion	zł18.38	-2.1%	3.1%	zł297.1m	zł15.83	PE7.2x	E-103.2%	n/a
	RVU Ryvu Therapeutics	zł55.80	10.1%	-3.6%	zł1.3b	zł73.13	PS17.3x	E-9.9%	n/a
	PUR Pure Biologics	zł7.50	3.4%	-55.9%	zł25.0m	n/a	PS229x	n/a	n/a

Page 1 of 1